Suspected Ocular Toxoplasmosis in Patients with ABCA4-Related Maculopathy - Top-Institutions - MDSpire

Suspected Ocular Toxoplasmosis in Patients with ABCA4-Related Maculopathy

  • By

  • Maram E. A. Abdalla Elsayed

  • Vincenzo Barone

  • Robert E. MacLaren

  • January 6, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts Eye and Ear Infirmary
    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Retinal Genetics
    • Inherited Retinal Diseases

  • #2

    Bascom Palmer Eye Institute, University of Miami
    Bascom Palmer Eye Institute, University of Miami

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Retinal Disease
    • Genetic Eye Disorders

  • #3

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Retinal Genetics
    • Inherited Retinal Diseases

  • #4

    University of California, San Francisco (UCSF) Department of Ophthalmology
    University of California, San Francisco (UCSF) Department of Ophthalmology

    San Francisco, CA

    Key Differentiators

    • Ophthalmology
    • Retinal Disease
    • Genetic Eye Disorders

Original Source(s)

Suspected Ocular Toxoplasmosis in Patients with ABCA4-Related Maculopathy

  • by Maram E. A. Abdalla Elsayed, Vincenzo Barone, Robert E. MacLaren

  • January 6, 2026

Related Content

Early Fluid Resolution Predicts Faricimab Durability

Post hoc analysis suggests rapid retinal fluid resolution may help identify patients with nAMD who can maintain longer faricimab dosing intervals.

Combination Therapy May Increase Lesion Closure in PCV

The combination of photodynamic therapy and intravitreal  aflibercept did not improve 1-year visual acuity outcomes compared with aflibercept monotherapy.

Equal Pay in Ophthalmology? Not Yet

A decade of AAMC salary data reveals a persistent gender pay gap in academic ophthalmology—and projects it will never close at senior ranks